VEGF Inhibitor Drugs Market Trends

Growth Drivers

• Rising Cases of Cancer to Boost the Market Growth

As per the World Health Organization, cancer is the second leading cause of death worldwide. It was predicted to cause about 9.6 million deaths in 2018. Further, approximately 1 in every 6 deaths is caused as a result of cancer. It has been observed that the number of cases of cancer are rising at a significantly high rate, which is predicted to continue to grow further in the coming years. On the back of this, the vascular endothelial growth factor inhibitors market for VEGF inhibitor drugs is anticipated to grow by the end of 2028.

• Growing Demand for Monoclonal Antibodies as Therapy to Drive the Market Growth

The research and development on monoclonal antibodies for the purpose of developing various treatment methods is estimated to be a major growth factor for the market. Moreover, the rising demand for combination therapies on account of their higher effectiveness than monotherapy drugs, especially in the case of various cancers, the vascular endothelial growth factor inhibitors market is anticipated to witness a huge growth opportunity.

Challenges

• High Cost of VEGF Inhibitor Drugs to Restrict the Market Growth

As the market for VEGF inhibitor drugs is currently of a moderate size, there is limited availability of these drugs in the market. Moreover, this results in the drugs being expensive and not affordable for the middle and lower class in various countries. In addition to this, the side effects associated with the use of VEGF inhibitor drugs are predicted to be another growth restricting factor for the market.